International Journal of Pharmacology1811-77751812-5700Asian Network for Scientific Information10.3923/ijp.2015.659.671SaidSaid A. El-SayedHassan A. AmrAbd El-Galil E. AbdallaMohamed M. 72015117A series of the newly substituted thienopyrimidine derivatives 2-13 were synthesized by using 3-amino-6-(4-chlorophenyl)-4-(4-isopropylphenyl) thieno[2,3-b]pyridine-2-carbohydrazide 1 as starting material. Reaction of compound 1 with p-nitrobenzaldehyde in refluxing ethanol afforded the corresponding Shiff base 2, which was cyclized with triethyl orthoformate to give thienopyrimidine derivative 3. Compound 1 was treated with formic acid or acetic anhydride to afford the corresponding thienopyrimidines 4 and 5, respectively. Treatment of 1 with acetylacetone afforded pyrazolothienopyrimidine 6. Treatment of 1 with triethyl orthoformate, carbon disulfide, dimethylformamide and ethyl acetoacetate or diethyl malonate gave compounds 7-11, respectively. Cyclization of 1 with m-nitrophthalic anhydride or formaldehyde afforded thienopyrimidines 12 and 13, respectively. The newly synthesized compounds were found to be potent selective and orally bioavailable CHK1 inhibitors. This elucidated and confirmed via determination of checkpoint abrogation, antiproliferative activity and potentiation of genotoxic drug efficacy in cancer cell lines and also determination of compound concentrations in vivo at selected time points following i.v. and oral dosing.]]>Mohamed, Y.A., A.E.G.E. Amr, S.F. Mohamed, M.M. Abdalla, M.A. Al-Omar and S.H. Shfik,2012124693702Abo-Ghalia, M. and A. Amr,2004Nα-dipicolinoyl) pentapeptide of a breast and CNS cytotoxic activity and an ionophoric specificity.]]>26283289Al-Omar, M.A. and A.E.E. Amr,20101547114721Amr, A.G.E., A.M. Mohamed, S.F. Mohamed, N.A. Abdel-Hafez and A.E.F.G. Hammam,20061454815488Amr, A.G.E., M.I. Hegab, A.A. Ibrahiem and M.M. Abdulla,200313413951409Bamborough, P., M.J. Brown, J.A. Christopher, C.W. Chung and G.W. Mellor,20115451315143Brana, M.F, J.M. Castellano, M. Moran, M.J.P. de Vega and C.R. Romerdahl et al.,19938257268Card, A., C. Caldwell, H. Min, B. Lokchander and H. Xi et al.,2008143142Chambhare, R.V., B.G. Khadse, A.S. Bobde and R.H. Bahekar,2003N-[5-(2-furanyl)-2-methyl-4-oxo-4H-thieno[2,3-d]pyrimidin-3-yl]-carboxamide and 3-substituted-5-(2-furanyl)-2-methyl-3H-thieno[2,3-d]pyrimidin-4-ones as antimicrobial agents.]]>3889100Dave, C.G. and R.D. Shah,20027554565De Clercq, E.,19866549556Dunne, J., H. Reardon, V. Trinh, E. Li and J. Farinas,20042121129Fahmy, H.H. and W. El-Eraki,200124171179Gillespie, E., K.W. Dungan, A.W. Gomoll and R.J. Seidehamel,19857655660Hopkins, A.L., C.R. Groom and A. Alex,20049430431Litvinov, V.P.,200453487516Matthews, T.P., T. McHardy, S. Klair, K. Boxall and M. Fisher et al.,20102040454049Abd El-Latif, N.A., A.E.G.E. Amr and A.A. Ibrahiem,2007138559567Perrin, D., C. Fremaux and A. Scheer,200611359368Rosowsky, A., M. Chaykovsky, K.K. Chen, M. Lin and E.J. Medest,197316185188Posy, S.L., M.A. Hermsmeier, W. Vaccaro, K.H. Ott and G. Todderud et al.,2011545466Santagati, N.A., A. Caruso, V.M. Cutuli and F. Caccamo,199550689695Skehan, P., R. Storeng, D. Scudiero, A. Monks and J. McMahon et al.,19908211071112Smyth, L.A., T.P. Matthews and I. Collins,20111935693578Walton, M.I., P.D. Eve, A. Hayes, M. Valenti and A.H. Brandon et al.,2010989100Chioua, M., A. Samadi, E. Soriano, O. Lozach, L. Meijer and J. Marco-Contelles,2009H-pyrazolo[3,4-b]pyridine derivatives as protein kinase inhibitors.]]>1945664569Dwyer, M.P., K. Paruch, M. Labroli, C. Alvarez and K.M. Keertikar et al.,2011a]pyrimidine-based CHK1 inhibitors: A template-based approach: Part 1.]]>21467470Ermoli, A., A. Bargiotti, M.G. Brasca, A. Ciavolella and N. Colombo et al.,2009H-Pyrrolo[2,3-b]pyridines, synthesis and structure-activity relationships.]]>5243804390Fu, R.G., Q.D. You, L. Yang, W.T. Wu, C. Jiang and X.L. Xu,2010b]pyridine and benzo[4,5]imidazo[1,2-a]pyrimidine compounds as dual KSP and Aurora-A kinase inhibitors for anti-cancer agents.]]>1880358043Kendall, J.D., P.D. O'Connor, A.J. Marshall, R. Frederick and E.S. Marshall et al.,2012a]pyridines as p110α-selective PI3 kinase inhibitors.]]>206985Lin, R., P.J. Connolly, Y. Lu, G. Chiu and S. Li et al.,2007b]pyridine CDK1 inhibitors as anti-tumor agents.]]>1742974302Shi, J., G. Xu, W. Zhu, H. Ye and S. Yang et al.,2010c]pyrazoles and pyrazolo[3,4-b]pyridines for Aurora-A kinase inhibitors.]]>2042734278Witherington, J., V. Bordas, S.L. Garland, D.M.B. Hickey and R.J. Ife et al.,2003b]pyridines: Potent inhibitors of glycogen synthase kinase-3 (GSK-3).]]>1315771580